 | Up a level |
Scheid, Christof, Reece, Donna, Beksac, Meral, Spencer, Andrew, Callander, Natalie 
ORCID: 0000-0002-6975-1086, Sonneveld, Pieter, Kalimi, Ghulam, Cai, Can, Shi, Michael, Scott, Jeffrey W. and Stewart, A. Keith
(2015).
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation.
Eur. J. Haematol., 95 (4).
S. 316 - 325.
HOBOKEN:
WILEY.
ISSN 1600-0609
Scheid, Christof, Reece, Donna, Beksac, Meral ORCID: 0000-0003-1797-8657, Spencer, Andrew, Callander, Natalie, Sonneveld, Pieter, Kalimi, Ghulam, Cai, Can, Shi, Michael, Scott, Jeffrey W. and Stewart, A. Keith
(2012).
A Phase 2, Multicenter, Nonrandomized, Open-Label Study of Dovitinib (TKI258) in Patients with Relapsed or Refractory Multiple Myeloma with or without t(4;14) Translocation.
Blood, 120 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 0006-4971
Wolf, Juergen, Garon, Edward B., Groen, Harry J. M., Tan, Daniel Shao-Weng, Gilloteau, Isabelle, Le Mouhaer, Sylvie, Cai, Can, Chassot-Agostinho, Andrea, Reynolds, Maria, Odom, Dawn and Heist, Rebecca Suk (2021). Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the phase II GEOMETRY mono-1 study. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755